CA
INDV icon

Clearstead Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Clearstead Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55K Buy
+111
New +$4.03K ﹤0.01% 2226
2026
Q1 		– Sell
-61
Closed -$2.19K – 2543
2025
Q4 		$2.19K Buy
+61
New +$1.86K ﹤0.01% 2130

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Advisors's INDV Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 111 shares worth $4.55K. The stake represents ﹤0.01% of the portfolio and ranks #2226 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in INDV as recently as Q4 2025.

Clearstead Advisors first reported a position in INDV in Q4 2025 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Clearstead Advisors held 111 shares of Indivior Pharmaceuticals worth $4.55K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Clearstead Advisors position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2226 holding.
  • Clearstead Advisors first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.